Healthcare Purchasing News
  • Magazine
  • Continuing Education
  • Webinars
  • Whitepapers
  • Videos
  • Events
  • Hall of Fame
  • Advertise
  • Source Guide
  • Subscribe
  • Sourcing & Logistics
  • Sterile Processing
  • Surgical & Critical Care
  • Patient Satisfaction
  • Infection Prevention
  • EVS & Facility Services
  • Healthcare IT
  • Regulatory
  • Topics
    Sourcing & LogisticsSterile ProcessingSurgical & Critical CarePatient SatisfactionInfection PreventionEVS & Facility ServicesHealthcare ITRegulatory
    Resources
    HPN Source GuideContinuing EducationWebinarsWhitepapersVideosEventsHall of FameAdvertiseAd Specs
    User Tools
    SubscribeContact UsAbout UseNewsletterMagazinesPrivacy PolicyTerms & Conditions
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    1. Surgical/Critical Care

    Two separate eye diseases may contribute to AMD

    Jan. 11, 2023
    Photo 115642753 / Background © Ivan Shidlovski | Dreamstime.com
    Dreamstime Xxl 115642753

    Two separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.

    The research, published in Eye is the first to demonstrate that two different types of deposits in the retina may contribute to early AMD, which can progress to advanced AMD and blindness. These two diseases could be diagnosed, studied, and treated separately with appropriate early intervention to prevent vision loss and other complications.

    Age-related macular degeneration results from damage to the central area of the retina called the macula, which is responsible for reading and driving vision for driving. Nearly 20 million Americans age 40 and older are living with some form of AMD, according to the Centers for Disease Control and Prevention (CDC). AMD in its early form is currently considered to be a single disease with cholesterol-containing deposits. These deposits are known as drusen and subretinal drusenoid deposits (SDDs). Early AMD may progress to blindness in two advanced forms, commonly called wet and dry AMD. The advanced dry form is also called geographic atrophy (GA) by eye specialists

    “An amazing fact is that the retina can generate a fluorescent light, similar to that of a light fixture, but a million times dimmer. For the first time, we were able to measure this dim light, called autofluorescence (AF), with ultra-sensitive detectors to study advanced AMD. We found it was consistently twice as bright in the patients with SDDs as those with drusen when they reached advanced AMD, and came from a unique diseased layer,” explains lead author R. Theodore Smith, MD, PhD, Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai. “Combined with our prior research, this provides conclusive evidence that two different disease processes in AMD are taking place, one with darker fluorescence and drusen, and one with brighter fluorescence and SDDs, and they need to be treated differently.”

    Drusen formation can be slowed by appropriate vitamin supplements to prevent vision loss. Currently, there is no known treatment for SDDs, and they pose a greater threat of advanced AMD. However, in a recent previous study, Dr. Smith and a team of Mount Sinai researchers found that patients with SDDs are likely to have heart damage from heart failure and heart attacks, or advanced heart valve disease, or strokes associated with carotid artery disease.

    “We think the SDDs result from deficient blood flow to the eye caused by these vascular diseases. We therefore believe that patients with SDDs should be warned they may have life-threatening undetected heart conditions that should be evaluated and treated. Further research needs to be done in women and disadvantaged groups where neglected heart disease is a serious issue. Eye scans for SDDs and routine cholesterol blood tests could address this. Additionally, treating the cardiovascular condition and restoring the eye’s blood supply may also help the SDDs. This work should prompt retinal specialists to look for both drusen and SDDs with optical coherence tomography (OCT), a standard retinal imaging technique, to best counsel patients.”

    Mount Sinai release

    Latest in Surgical/Critical Care

    621037713 © LAYHONG| stock.adobe.com
    Surgical/Critical Care

    Horizon-scanning next-generation surgical beds, tables, exam chairs

    Rick Dana Barlow
    Nov. 28, 2023
    Photo 170837495 © Thanee Hengpattanapong | Dreamstime.com
    Surgical/Critical Care

    FDA: Do Not Use Cardinal Health Monoject Syringes with Syringe Pumps and PCA Pumps

    Nov. 27, 2023
    Photo 27013405 © Hongqi Zhang (aka Michael Zhang) | Dreamstime.com
    Surgical/Critical Care

    The 3 Pillars to Reduce Healthcare Drug Diversion Among Nurses with Substance Use Disorder

    Deborah Koivula RN, BSN, CARN
    Nov. 20, 2023
    Photo 165865963 © Andrew Norris | Dreamstime.com
    Surgical/Critical Care

    FDA issues letter to healthcare providers about labeling updates for BD surgical mesh products

    Nov. 15, 2023
    Photo 1423201 | Blood © Geopappas | Dreamstime.com
    Surgical/Critical Care

    Different transfusion approaches for helping heart attack patients who develop anemia

    Nov. 13, 2023
    Healthcare Purchasing News
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    • About Us
    • Contact Us
    • Advertise
    • Do Not Sell or Share
    • Privacy Policy
    • Terms & Conditions
    © 2023 Endeavor Business Media, LLC. All rights reserved.
    Endeavor Business Media Logo